This checklist is a practical tool for clinical development professionals at sponsor and CRO organizations. It reflects regulatory guidance (FDA,...
Diabetes, obesity, heart failure, chronic kidney disease, and atherosclerosis often overlap, creating layered eligibility barriers that complicate patient enrollment in...
Study Objectives Study enrollment goal of 300 participants across 140 sites, across 17 countries. Alliance Clinical Network Goal: Enroll 1...
Study Objectives Enrollment of 416 participants, across 100 sites, study wide Alliance Clinical Network Goal: Enroll 10 participants ChallengesDuring the...
Conducting clinical trials in Type 2 Diabetes (T2D) presents a unique set of challenges at the site level. Sites are...
The following table provides a brief history of GLP-1 therapies that have received FDA regulatory approval. In addition to identifying...
5 Minute Read Obesity is a growing global health issue, with its prevalence reaching epidemic proportions. Affecting more than one...
